Literature DB >> 32546555

Symptomatic digoxin toxicity in a patient on haemodialysis.

Lara Delicata1, Arlène Gatt2, Jean-Luc Paris2, John Bonello3.   

Abstract

We present a man undergoing regular haemodialysis sessions, who presented with non-specific symptoms of nausea, vomiting and light-headedness. He was found to have significantly raised serum digoxin concentrations, as well as a heart rate of 30 beats per minutes. An ECG showed complete heart block. He has a history of non-ischaemic dilated cardiomyopathy with resistant supraventricular and ventricular tachycardias and was on concomitant beta-blockade and digoxin. On questioning, he reported a gradual decline in his residual urine output over the past 6 months. He was reviewed by the cardiology team and required both pharmacological therapy for reversal of digoxin toxicity and temporary pacing in view of significant bradyarrhythmias. The beta-blockade and digoxin were discontinued. He was kept on continuous monitoring at the Cardiac Critical Care Unit. His symptoms resolved spontaneously once digoxin-specific antibody fragments were administered and temporary pacing successfully performed. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  arrhythmias; dialysis; renal system; toxicology

Mesh:

Substances:

Year:  2020        PMID: 32546555      PMCID: PMC7299017          DOI: 10.1136/bcr-2020-234899

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  7 in total

1.  Digoxin toxicity: Case for retiring its use in elderly patients?

Authors:  Nora MacLeod-Glover; Matthew Mink; Mark Yarema; Ryan Chuang
Journal:  Can Fam Physician       Date:  2016-03       Impact factor: 3.275

2.  Digoxin associates with mortality in ESRD.

Authors:  Kevin E Chan; J Michael Lazarus; Raymond M Hakim
Journal:  J Am Soc Nephrol       Date:  2010-06-24       Impact factor: 10.121

3.  Digoxin-specific Fab and therapeutic plasma exchange for digitalis intoxication and renal failure.

Authors:  Marta Pellegrino; Mattia Garofalo
Journal:  Am J Emerg Med       Date:  2019-01-22       Impact factor: 2.469

4.  Digoxin intoxication in a patient with end-stage renal disease: efficacy of digoxin-specific Fab antibody fragments and peritoneal dialysis.

Authors:  O Caspi; E Zylber-Katz; O Gotsman; D G Wolf; Y Caraco
Journal:  Ther Drug Monit       Date:  1997-10       Impact factor: 3.681

5.  Renal function, digoxin therapy, and heart failure outcomes: evidence from the digoxin intervention group trial.

Authors:  Michael G Shlipak; Grace L Smith; Saif S Rathore; Barry M Massie; Harlan M Krumholz
Journal:  J Am Soc Nephrol       Date:  2004-08       Impact factor: 10.121

Review 6.  Extracorporeal treatment for digoxin poisoning: systematic review and recommendations from the EXTRIP Workgroup.

Authors:  James B Mowry; Emmanuel A Burdmann; Kurt Anseeuw; Paul Ayoub; Marc Ghannoum; Robert S Hoffman; Valery Lavergne; Thomas D Nolin; Sophie Gosselin
Journal:  Clin Toxicol (Phila)       Date:  2016       Impact factor: 4.467

Review 7.  Management of digoxin toxicity.

Authors:  Matthew Pincus
Journal:  Aust Prescr       Date:  2016-02-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.